Publication | Closed Access
Bevacizumab and Aflibercept Activate Platelets via FcγRIIa
18
Citations
29
References
2015
Year
A complex composed of bevacizumab or aflibercept, but not ranibizumab, and growth factors activates platelets via FcγRIIa.
| Year | Citations | |
|---|---|---|
Page 1
Page 1